Responses
Poster Presentations
Psoriatic arthritis
THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials
Compose a Response to This Article
Other responses
No responses have been published for this article.